Navigation Links
New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge
Date:6/7/2012

FARMINGTON, Conn., June 4, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce the immediate availability of a new report and new research tool for cancer drug research and development companies and market analysts:

Oncology Drug Pathway Analyzer

Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. The Oncology Drug Pathway Analyzer from BioSeeker Group AB is an interactive data tool to analyze thousands drug-pathway connections in close to 90 different cancer indications. This tool allows users to examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).

With the Oncology Drug Pathway Analyzer, users can review their competition and find suitable benchmarking drugs, basing their search on specific pathways and drug properties. This will allow companies to uncover potential indication expansion areas for their drug portfolios, reveal repositioning opportunities for their older, shelved drugs, and evaluate the progression and success of targeting certain pathways for the treatment of cancer. This tool will also help users investigate different therapy combination options available for various cancer types, and reveal for the most-efficient ways to combine their drugs with other targeted agents.

A detailed description of the tool and a real case scenario are available at http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html

Cancer Treatment Drugs Markets in China

As China's continued rise as a modern economy proves to be a significant growth sector, demand for cancer treatment drugs across their nation has grown at a quick pace over the past decade, with both production and demand forecast to continue to this steady growth in the next five years.

Now, Global Information is pleased to make available a collection of 12 complete cancer drug market research reports from Asia Market Information & Development on the Chinese Cancer treatment drugs market, covering the following cancers: lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs.

The reports include market trends, developments, with market forecasts through 2016 and 2021.

A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/amid243405-cancer-treatment-drugs-markets-china-12-full.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Worlds largest release of comprehensive human cancer genome data helps speed discoveries
2. New musical pacifier helps premature babies get healthy
3. Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
4. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
5. Gene signature helps identify risk of relapse in lung cancer patients
6. New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
7. University of Minnesota invention helps advance reliability of alternative energy
8. New iPad, iPhone app helps mariners avoid endangered right whales
9. Newly found protein helps cells build tissues
10. Protein jailbreak helps breast cancer cells live
11. Computer sleuthing helps unravel RNAs role in cellular function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
Breaking Biology Technology: